PTEN Expands Equity Plan and Refinances With 2036 Notes
NEW YORK, June 5 —
Patterson-UTI Energy shareholders voted at the June 4 annual meeting to expand the company's equity plan, formalizing a new dilution mechanism even as the oilfield services driller completed a debt refinancing and its top executives cashed out at a pace that commands attention. Over the five weeks preceding the vote, the CEO, COO, and a director collectively sold $9.43 million in shares with no open-market purchases on the other side of the ledger.
- $9.43 million in net insider selling over the trailing 90 days — CEO, COO, and a director — zero purchases recorded
- Q1 2026 EPS of -$0.02 beat the -$0.10 consensus, per the April 23 earnings 8-K
- Trailing-twelve-month revenue of $4.66 billion, down 12.7% year-over-year
The Selling Pattern
The specific cadence matters. On May 1 — four days after a Material Definitive Agreement 8-K filed April 28 and the same day Director Robert Drummond sold 322,699 shares at $12.04 — President and CEO William Hendricks sold 250,000 shares at $11.85, collecting $2.96 million. Drummond followed on May 4 with another 61,475 shares at $12.02, bringing his combined total to approximately $4.62 million across both transactions.
EVP and COO James Holcomb added to the pattern on May 28, selling 150,000 shares at $11.47 for $1.72 million. Net across all insiders over the trailing 90 days: $9.43 million sold, zero purchased. Open-market buying is the credibility vote that was never cast.
The Refinancing Move
Concurrent with the selling, Patterson-UTI extended its debt runway. A 424B5 prospectus supplement filed May 6 preceded an 8-K disclosing the Material Definitive Agreement on May 19, locking in 2036 senior notes. Pushing maturities a decade out reduces near-term liquidity pressure — a sensible move for a cyclical business facing a revenue headwind. The question is whether the refinancing buys time for a demand recovery or merely defers a reckoning. Trailing revenue has already declined 12.7%.
A Beat That Didn't Excite the C-Suite
The Q1 earnings beat deserves context. Patterson-UTI posted EPS of -$0.02 against a -$0.10 consensus — a clean beat on a low bar. Losing money at a slower-than-expected rate is progress of a specific kind. The CEO and COO treated the disclosure as a selling opportunity rather than a moment to add exposure. Executives who believe the recovery story buy stock after a beat; they don't accelerate exits.
The revenue picture reinforces the skepticism. Trailing-twelve-month revenue of $4.66 billion represents a 12.7% year-over-year decline. Oilfield services companies live and die by rig count and E&P capital spending. Neither metric is showing the kind of inflection that would justify aggressive re-rating.
What to Watch
The equity plan expansion approved at the June 4 annual meeting adds another dilution layer. New shares can provide equity-based retention through a downturn, but they also dilute existing holders who stayed while insiders were selling. Combined with the 2036 notes refinancing, the picture is a company managing its liabilities and incentive structures for a prolonged environment, not one positioning for an imminent upcycle.
The next inflection point is Q2 results. If revenue contraction stabilizes or reverses, the bear case softens. If insiders remain net sellers into any price strength, the signal is unambiguous. For now, the sum of the evidence — concentrated C-suite selling and a loss-making P&L despite the Q1 beat — points toward caution rather than conviction. Run the free Patterson-UTI Energy, Inc. deep-dive → /stock/pten
Basis Report does not hold positions in securities discussed. This is not investment advice.
Frequently Asked Questions
What did Patterson-UTI insiders sell recently?
CEO William Hendricks Jr. sold 250,000 shares at $11.85 on May 1, 2026, totaling $2.96 million. COO James Holcomb sold 150,000 shares at $11.47 on May 28, 2026, totaling $1.72 million. Director Robert Drummond sold approximately $4.62 million across two transactions on May 1 and May 4. Combined net insider selling over the trailing 90 days totaled $9.43 million with zero open-market purchases recorded.
What were Patterson-UTI Q1 2026 earnings results?
Patterson-UTI reported Q1 2026 EPS of -$0.02, beating the consensus estimate of -$0.104, per an 8-K filed April 23, 2026. Despite the beat, the company still posted a net loss in the quarter. Trailing twelve-month revenue stood at $4.66 billion, down 12.7% year-over-year.
What are the Patterson-UTI 2036 senior notes?
Patterson-UTI refinanced with 2036 senior notes, confirmed by a 424B5 prospectus supplement filed May 6, 2026 and an 8-K disclosing a Material Definitive Agreement filed May 19, 2026. The refinancing extends the company's debt maturity profile but layers long-dated obligations onto a business with declining revenue.
Did shareholders approve the Patterson-UTI equity plan expansion?
Yes. At the June 4, 2026 annual meeting, shareholders voted to approve an equity plan expansion, per the 8-K filed that day. The approval grants management a larger pool of stock-based compensation authority, which carries a dilutive effect for existing shareholders over time.
Is Patterson-UTI stock a buy or sell right now?
Recent filings lean bearish. Three senior insiders sold a combined $9.43 million in stock with no open-market purchases, while revenue contracted 12.7% year-over-year and Q1 2026 still produced a net loss despite beating estimates. The deep-dive at /stock/pten provides additional financial data for further evaluation.